Long-term survival of CML patients who received autologous HCT before and after the tyrosine kinase inhibitors ERA. Study on behalf of the EBMT CMWP

Affiliation auteurs!!!! Error affiliation !!!!
TitreLong-term survival of CML patients who received autologous HCT before and after the tyrosine kinase inhibitors ERA. Study on behalf of the EBMT CMWP
Type de publicationJournal Article
Year of Publication2019
AuteursMichallet M, Sobh M, Hazelaar S, Apperley J, Milpied N, Labussiere-Wallet H, Blaise D, Foa R, Sierra J, Deconinck E, Angelucci E, Carlson K, Porras RParody, Ganser A, Sanz J, Mohty M, Vittorio R, Clark RE, Patel A, Mistrik M, McQuaker G, Chevallier P, Zuckerman T, Anagnostopoulos A, Nicolini FE, Chalandon Y, Yakoub-Agha I
JournalBONE MARROW TRANSPLANTATION
Volume54
Pagination201-202
Date PublishedJUL
Type of ArticleMeeting Abstract
ISSN0268-3369